Crestline Management’s Amicus Therapeutics FOLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-123,222	Closed	-$1.77M	–	224
2017 Q4	$1.77M	Buy	123,222 +70,377	+133%	+$1.01M	0.18%	46
2017 Q3	$797K	Buy	+52,845	New	+$797K	0.11%	111
2017 Q2	–	Sell	-134,200	Closed	-$957K	–	145
2017 Q1	$957K	Buy	+134,200	New	+$957K	0.18%	57